Symptoms of Lithium Toxicity
Lithium toxicity presents with a progressive spectrum of symptoms that correlate with serum levels, starting with gastrointestinal and neuromuscular signs (diarrhea, vomiting, tremor, weakness) at levels below 2 mEq/L, advancing to neurological impairment (ataxia, confusion, blurred vision) at higher levels, and potentially causing multi-organ dysfunction above 3 mEq/L 1.
Early Warning Signs (Often <2 mEq/L)
The earliest indicators of lithium toxicity include 1:
- Diarrhea and vomiting
- Drowsiness
- Muscular weakness
- Lack of coordination
These symptoms can appear even at therapeutic levels in sensitive patients or those with risk factors 1, 2, 3.
Progressive Neurological Symptoms (Levels 1.5-3 mEq/L)
As toxicity worsens, the clinical picture becomes dominated by neurological manifestations 1:
Motor symptoms:
- Coarse tremor (distinct from the fine tremor seen at therapeutic levels)
- Ataxia and giddiness
- Muscle hyperirritability (fasciculations, twitching)
- Choreo-athetotic movements
- Hyperactive deep tendon reflexes
Cognitive and sensory symptoms:
- Confusion and cognitive decline 4
- Slurred speech
- Blurred vision
- Tinnitus
- Visual hallucinations 4
- Somnolence to stupor
Severe neurological signs:
- Seizures
- Coma
- Blackout spells
- Incontinence
Systemic Manifestations
Beyond the central nervous system, lithium toxicity affects multiple organ systems 1:
- Renal: Polyuria with dilute urine (large output), oliguria in severe cases
- Cardiovascular: Cardiac arrhythmias, hypotension, severe bradycardia, peripheral circulatory collapse
- Gastrointestinal: Persistent nausea, vomiting, diarrhea, anorexia
Critical Clinical Pitfall
A crucial caveat: Patients can exhibit significant lithium toxicity even with "therapeutic" or "normal" serum lithium levels 2, 3. This occurs particularly in:
- Elderly patients 3
- Those with chronic kidney disease 2
- Patients on interacting medications 5
- Dehydrated or febrile patients 3
In one documented case, a patient with over 20 years of stable lithium therapy developed severe toxicity with coarse tremor despite normal serum levels 2. Another case showed complete resolution of neurological symptoms (tremors, hallucinations, ataxia, cognitive decline) only after lithium discontinuation despite therapeutic blood levels 3.
Severity Stratification by Serum Level
The FDA label provides clear thresholds 1:
- >1.5 mEq/L: Increased toxicity risk begins
- <2 mEq/L: Early symptoms (GI, weakness, tremor) predominate
- >2 mEq/L: Should not be permitted during acute treatment
- >3 mEq/L: Complex multi-organ toxicity expected
Pattern Recognition
Lithium toxicity follows three patterns 6:
- Acute: Single large ingestion
- Acute-on-chronic: Therapeutic patient with acute overdose
- Chronic: Most common, usually unintentional from impaired elimination
Chronic toxicity typically results from volume depletion (often from lithium-induced nephrogenic diabetes insipidus), intercurrent illness, or drug interactions 6, 5. In one retrospective study, 50% of toxicity cases involved interacting medications 5.
Monitoring Beyond Numbers
When evaluating suspected lithium toxicity, treat the clinical presentation, not just the serum level 2. Neurological symptoms (tremor, confusion, ataxia, drowsiness) were the most common findings in a 5-year retrospective review, occurring in the majority of 130 toxicity cases 5. EEG can support the diagnosis of chronic lithium toxicity even when levels appear therapeutic 3.